Oregon Public Employees Retirement Fund Neurocrine Biosciences Inc Transaction History

Oregon Public Employees Retirement Fund

$5.08 Billion
Q3 2024

A detailed history of Oregon Public Employees Retirement Fund transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Oregon Public Employees Retirement Fund holds 20,516 shares of NBIX stock, worth $2.41 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

20,516

Previous 20,952 2.08%

Holding current value

$2.41 Million

Previous $2.88 Million 18.1%

% of portfolio

0.05%

Previous 0.06%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$114.58 - $153.15 $49,956 - $66,773	-436 Reduced 2.08%	20,516 $2.36 Million
Q2 2024 Aug 01, 2024	SELL	$130.86 - $143.19 $476,722 - $521,641	-3,643 Reduced 14.81%	20,952 $2.88 Million
Q1 2024 May 02, 2024	SELL	$130.4 - $143.74 $413,759 - $456,087	-3,173 Reduced 11.43%	24,595 $3.39 Million
Q4 2023 Feb 12, 2024	BUY	$106.07 - $132.76 $36,169 - $45,271	341 Added 1.24%	27,768 $3.66 Million
Q3 2023 Oct 26, 2023	SELL	$94.02 - $117.1 $68,634 - $85,483	-730 Reduced 2.59%	27,427 $3.09 Million
Q2 2023 Jul 26, 2023	SELL	$89.53 - $104.87 $1.19 Million - $1.39 Million	-13,267 Reduced 32.03%	28,157 $2.66 Million
Q1 2023 May 04, 2023	BUY	$94.11 - $123.02 $6,681 - $8,734	71 Added 0.17%	41,424 $4.19 Million
Q4 2022 Jan 26, 2023	BUY	$106.72 - $127.06 $1.44 Million - $1.71 Million	13,455 Added 48.23%	41,353 $0
Q3 2022 Nov 01, 2022	BUY	$92.03 - $107.81 $50,892 - $59,618	553 Added 2.02%	27,898 $2.96 Million
Q2 2022 Jul 25, 2022	SELL	$75.79 - $100.07 $227,370 - $300,210	-3,000 Reduced 9.89%	27,345 $2.67 Million
Q1 2022 Apr 21, 2022	SELL	$72.45 - $94.81 $50,715 - $66,367	-700 Reduced 2.25%	30,345 $2.85 Million
Q4 2021 Feb 01, 2022	SELL	$79.65 - $106.22 $63,162 - $84,232	-793 Reduced 2.49%	31,045 $2.64 Million
Q3 2021 Oct 19, 2021	SELL	$86.18 - $99.03 $36,195 - $41,592	-420 Reduced 1.3%	31,838 $3.05 Million
Q2 2021 Jul 23, 2021	BUY	$89.43 - $102.27 $81,917 - $93,679	916 Added 2.92%	32,258 $3.14 Million
Q1 2021 Apr 20, 2021	BUY	$87.57 - $119.4 $2.67 Million - $3.64 Million	30,453 Added 3425.53%	31,342 $3.05 Million
Q4 2020 Feb 09, 2021	SELL	$86.91 - $108.33 $721,353 - $899,139	-8,300 Reduced 90.33%	889 $85,000
Q3 2020 Nov 03, 2020	SELL	$96.16 - $135.15 $57,696 - $81,090	-600 Reduced 6.13%	9,189 $883,000
Q2 2020 Jul 21, 2020	BUY	$85.09 - $130.36 $832,946 - $1.28 Million	9,789 New	9,789 $1.19 Million

Others Institutions Holding NBIX

# of Institutions

623

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.2B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.

Account

Oregon Public Employees Retirement Fund Neurocrine Biosciences Inc Transaction History